A partnership between the University of Cincinnati and Cincinnati Children’s Hospital has landed more than $37 million in ...
Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, has been awarded a three-year Small Business Innovation Research Grant (SBIR) Phase II for a project titled ...
Researchers found that pembrolizumab, an immune-activating cancer drug, lowered the risk of distant metastases in patients ...
MedPage Today on MSN
Understanding Osteoporosis in Older Men
These include the RANKL inhibitor denosumab (Prolia), the anabolic agents teriparatide (Forteo) and abaloparatide (Tymlos), ...
News-Medical.Net on MSN
Largest trial of adjuvant pembrolizumab in Merkel cell carcinoma reports key benefit
A new cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) shows that a drug that utilizes the body's ...
MyNewsLA.com on MSN
New LA Research Center Funded by NIH for Study of Aging
A new Los Angeles research center has been funded by the National Institute on Aging to investigate such challenges as helping people live longer, healthier and more independently as they get older, ...
News Medical on MSN
Digital Program Spurs Lung Cancer Screening Uptick
"Our study shows that reaching patients directly with digital tools can help overcome barriers to lung cancer screening and ...
How are clinicians to preserve core clinical skills in an era of algorithmic assistance? As artificial intelligence (AI) assumes a growing role in clinical practice, concern is mounting that ...
A drug that harnesses the immune system to attack cancer cells has proved successful in preventing a rare and aggressive form ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results